Key points are not available for this paper at this time.
Design
Review
Clinicians should exercise caution with QT-prolonging agents; review leaves open optimal risk-stratification and mitigation strategies.
Although the use of QT-prolonging medications can predispose to torsades de pointes, there is a relative paucity of information that can help clinicians and patients make optimal informed decisions about how best to minimize the risk of this serious complication.
No takes yet. Share an insight, caveat, or question.
Al‐Khatib et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: